Semaglutide is a GLP-1-RA that is FDA-approved for type 2 diabetes as semaglutide 2.0mg and for obesity as semaglutide 2.4mg. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.